About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Measles Outbreak Kills Nearly 70 People in Philippines

by Adeline Dorcas on February 12, 2019 at 4:17 PM
Font : A-A+

Measles Outbreak Kills Nearly 70 People in Philippines

Measles outbreak claims nearly 70 lives in Philippines. Measles, also known as morbilli or rubeola or red measles, is the most deadly childhood rash or fever illnesses that spreads very easily.

At least 70 people, mostly children under four years of age, have been confirmed dead due to the measles outbreak in the Philippines and the authorities are blaming vaccine hesitancy for the health crisis.

Advertisement


The deaths occurred since the beginning of the year, but the Health Department in a statement said the outbreak intensified last week and over 4,300 people were taken ill with symptoms of measles - a very contagious disease transmitted through air, Efe news reported.

The authorities put five regions on alert, although the highest number of affected people were reported from Manila and its suburbs.

An intensive vaccination programme was launched for children in the National Capital Region to prevent further proliferation of the disease which infects respiratory system of its victim and can result in severe diarrhea, pneumonia, blindness, and even death.
Advertisement

"Regions with high reported cases are NCR (1,296 cases and 18 deaths) Calabarzon (1,086 cases and 25 deaths), Central Luzon (481 cases with 3 deaths), Western Visayas (212 cases and 4 deaths) and Northern Mindanao (189 cases and 2 deaths)," the Health Department said.

The outbreak of the disease was being attributed to the lack of vaccination among children in recent years. Around 2.5 million Filipino children under the age of five didn't receive the necessary immunization shots.

Many Philippine parents refused to vaccinate their children due to the scandal surrounding Dangvaxia, an anti-dengue vaccine which was used in the country between 2014 and 2017, until its manufacturer, the French pharmaceutical company Sanofi Pasteur, admitted that it carried adverse effects and the vaccinated people who contracted dengue for the first time suffered more severe effects.

Health Secretary Francisco Duque III appealed to the public to repose their trust and confidence in immunization programmes.

Source: IANS
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Tropical Disease News

Oral Cholera Vaccine Launched in India by Pharma Giants
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Evolving Threat of Dengue Virus in India
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
 Watch Out for Acute Kidney Disease as a Complication of Malaria
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
India's Malaria Vaccine Gets the Green Light for First Time in Ghana
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
 Deadly Dengue Virus Hijacks Mosquito Saliva to Spread Sickness
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Measles Outbreak Kills Nearly 70 People in Philippines Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests